An open multicenter, phase III study of photodynamic therapy with Metvix cream [Methyl aminolevulinate] 160 mg/g in patients with `high risk' basal cell carcinoma.
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Sponsors PhotoCure
- 13 Jul 2007 New trial record.